
EFT-508

* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS No. | 1849590-01-7 | Cat. No. | BCP18993 |
Name | EFT-508 | ||
Synonyms | EFT 508;EFT508;Tomivosertib; | ||
SMILES | |||
Chemical Name | |||
Formula | C17H20N6O2 | M. Wt | 340.38 |
Purity | 98% | Storage | Store at 4-8°C |
Description | In vitro: eFT508 has a half-maximal inhibitory concentration (IC50) of 1-2 nM against both MNK isoforms in enzyme assays and inhibits the kinase through a reversible, ATP-competitive mechanism of action. eFT508 showed anti-proliferative activity against multiple DLBCL cell lines. In vivo: eFT508 is tested in vivo in 7 subcutaneous human lymphoma xenograft models. Significant anti-tumor activity is observed in the TMD8 and HBL-1 ABC-DLBCL models, both of which harbor activating MyD88 mutations. |
Recommend Products
More >Tags:EFT-508 supplier,EFT-508 purchase,EFT-508 manufacturer,EFT-508 distributor,EFT-508 cost,EFT-508 buy,EFT-508 for sale